General Information of the Compound
Compound ID
CP0451372
Compound Name
US9428503, 53
    Show/Hide
Structure
Formula
C29H34FN5O3
Molecular Weight
519.621
Canonical SMILES
Cn1c2cnc3cc(F)c(cc3c2n(C2CCOCC2)c1=O)-c1ccc(OCCCN2CCCCC2)nc1
    Show/Hide
InChI
InChI=1S/C29H34FN5O3/c1-33-26-19-31-25-17-24(30)22(16-23(25)28(26)35(29(33)36)21-8-14-37-15-9-21)20-6-7-27(32-18-20)38-13-5-12-34-10-3-2-4-11-34/h6-7,16-19,21H,2-5,8-15H2,1H3
    Show/Hide
InChIKey
QHRPXFUAYFWEPQ-UHFFFAOYSA-N
Physicochemical Property
logP
4.6956
Rotatable Bonds
7
Heavy Atom Count
38
Polar Areas
74.41
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
8
Complexity
38

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118523423
ChEMBL ID
CHEMBL3946515
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01045, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000218 BT-474 Homo sapiens (Human)  1
1
IC50 > 16700 nM
   TI
   LI
   LO
   TS
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000007 HT-29 Homo sapiens (Human)  2
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS
2
IC50 = 1.2 nM
   TI
   LI
   LO
   TS
Protein ID: PT01934, Serine/threonine-protein kinase ATR
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000007 HT-29 Homo sapiens (Human)  2
1
IC50 > 27100 nM
   TI
   LI
   LO
   TS
2
IC50 > 29000 nM
   TI
   LI
   LO
   TS